Literature DB >> 8705999

Frequent coordinated overexpression of the MRP/GS-X pump and gamma-glutamylcysteine synthetase genes in human colorectal cancers.

M T Kuo1, J J Bao, S A Curley, M Ikeguchi, D A Johnston, T Ishikawa.   

Abstract

We have recently shown that multidrug resistance-associated protein (MRP) and gamma-glutamylcysteine synthetase (gamma-GCS) heavy subunit genes are coordinately overexpressed in cisplatin-resistant human leukemia cells (T. Ishikawa et al. J. Biol. Chem., 271: 14981-14988, 1996). Using the RNase protection assay, we examined expression levels of these genes in colon tumor and nontumorous biopsy specimens from 32 cancer patients who had not been treated with chemotherapy. Increased mRNA levels (P < 0.001) of MRP and gamma-GCS genes were observed in 16 (50%) and 20 (62%) tumor samples, respectively. More importantly, all of the 16 (100%) MRP-overexpressing tumor specimens also exhibited higher levels of gamma-GCS mRNA than those in the matched nontumorous specimens. The correlation coefficient between MRP and gamma-GCS mRNA levels was r = 0.78 for all of the tumor samples studied. These results strongly suggest that MRP and gamma-GCS genes are coordinately up-regulated during colorectal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8705999

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

Review 1.  MRP subfamily transporters and resistance to anticancer agents.

Authors:  G D Kruh; H Zeng; P A Rea; G Liu; Z S Chen; K Lee; M G Belinsky
Journal:  J Bioenerg Biomembr       Date:  2001-12       Impact factor: 2.945

Review 2.  ATP-binding cassette efflux transporters in human placenta.

Authors:  Zhanglin Ni; Qingcheng Mao
Journal:  Curr Pharm Biotechnol       Date:  2011-04       Impact factor: 2.837

3.  Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.

Authors:  Helen H W Chen; Macus Tien Kuo
Journal:  Met Based Drugs       Date:  2010-09-14

Review 4.  Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities.

Authors:  Macus Tien Kuo
Journal:  Antioxid Redox Signal       Date:  2009-01       Impact factor: 8.401

5.  Anti-cancer-prostaglandin-induced cell-cycle arrest and its modulation by an inhibitor of the ATP-dependent glutathione S-conjugate export pump (GS-X pump).

Authors:  T Ishikawa; K Akimaru; M Nakanishi; K Tomokiyo; K Furuta; M Suzuki; R Noyori
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

6.  A new aspect on glutathione-associated biological function of MRP/GS-X pump and its gene expression.

Authors:  T Ishikawa; M T Kuo; K Furuta; M Suzuki
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

7.  Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.

Authors:  R Lacave; F Coulet; S Ricci; E Touboul; A Flahault; J G Rateau; D Cesari; J P Lefranc; J F Bernaudin
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

8.  Endogenous antioxidant enzymes and glutathione S-transferase in protection of mesothelioma cells against hydrogen peroxide and epirubicin toxicity.

Authors:  K Kinnula; K Linnainmaa; K O Raivio; V L Kinnula
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

9.  Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs.

Authors:  T Oguri; Y Fujiwara; T Isobe; O Katoh; H Watanabe; M Yamakido
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

10.  Synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and its inhibition of liver cancer characteristics in vitro and in vivo.

Authors:  Mingrong Cheng; Xiaoyan Gao; Yong Wang; Houxiang Chen; Bing He; Hongzhi Xu; Yingchun Li; Jiang Han; Zhiping Zhang
Journal:  Mar Drugs       Date:  2013-09-17       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.